nifedipine has been researched along with EHS Tumor in 3 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thews, O | 2 |
| Hummel, M | 1 |
| Kelleher, DK | 2 |
| Lecher, B | 1 |
| Vaupel, P | 2 |
| Biaglow, JE | 1 |
| Varnes, ME | 1 |
| Jacobson, B | 1 |
| Suit, HD | 1 |
3 other studies available for nifedipine and EHS Tumor
| Article | Year |
|---|---|
Nifedipine improves blood flow and oxygen supply, but not steady-state oxygenation of tumours in perfusion pressure-controlled isolated limb perfusion.
Topics: Animals; Calcium Channel Blockers; Cell Respiration; Chemotherapy, Cancer, Regional Perfusion; Infus | 2002 |
No improvement in perfusion and oxygenation of experimental tumors upon application of vasodilator drugs.
Topics: Animals; Infusions, Intravenous; Laser-Doppler Flowmetry; Male; Nifedipine; Nitroprusside; Oxygen; R | 2001 |
Effect of calcium channel blocking drugs on tumor cell oxygen utilization.
Topics: Animals; Calcium Channel Blockers; Cell Line; Diltiazem; Fibrosarcoma; Glucose; Kinetics; Mammary Ne | 1986 |